orphan reach™– the first global Contract Research Organisation (CRO) purely dedicated to rare diseases.

We are here to accelerate the clinical development of orphan drugs and facilitate patient access to urgently needed new treatments for rare conditions.

For our customers – innovative biotech companies – we provide global CRO services with particular attention to patient recruitment and retention enhanced by home nursing and patient travel support. As an organization that is used to operate trials in small patient populations we have developed the required translatable skills and understanding of the challenges of rare diseases that make us stand out from the crowd.

Our infrastructure allows access to patients with rare diseases in more than 100 countries world-wide. With centrally based Project Management teams in Europe, USA and Asia we co-ordinate our workforce on the ground in each of the local territories and contribute our orphan expertise to accelerate access to new drugs in a wide range of therapeutic areas.

orphan reach Brochure
Rare Disease Experience
Request For A Proposal

Global Coverage

orphan reach has a well established global presence in the majority of countries across each of the major continents. Our highly experienced local teams on the ground in these regions mean we are in a position to advise you of requirements, regulations and potential challenge particular to the locality.

Rare Disease Focus

Our services are tailored to accommodate clinical trials globally involving small patient numbers and to deal with the particular medical, scientific, clinical and commercial challenges within the rare disease domain.

 

Experienced Team

Our highly experienced and motivated team, backed by our resolute commitment to quality will enhance this drug development process for the benefit of all. We undertake our mission with dedication to flexibility, operational excellence and cost effectiveness. Our team is driven by passion.